Amid ongoing global shortages of semaglutide, the active ingredient in medical sensations Ozempic and Wegovy, researchers have uncovered a way to make 10 times more of the stuff, producing a ...

Semaglutide is part of the glucagon-like peptide-1 (GLP-1) receptor targeting family of peptide drugs which are mainly used to treat diabetes but are difficult and expensive to make.

Discovery could help reduce global shortage of diabetes and weight loss drug semaglutide. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 03 / 240318142453.htm ...